FDA Approves Metoclopramide Nasal Spray for Diabetic Gastroparesis FDA Approves Metoclopramide Nasal Spray for Diabetic Gastroparesis

The product, called Gimoti, delivers metoclopramide through nasal administration, offering an advantage over oral administration.FDA Approvals
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Alert Source Type: news